This study was used to evaluate the effects of low-pressure hyperbaric oxygen therapy (HBOT) on fatigue, pain, endurance and functional capacity, physical performance and cortical excitability when compared with a physical exercise program in women with fibromyalgia. The hyperbaric protocol used was a 2 month course of daily 90 minute sessions (5 days per week for a total of 40 hours) at 1.45 ATA. During this time period, 60 minutes of low intensity exercises, twice weekly (for a total of 16 sessions), was included in the protocol. This group of participants showed improvements in pressure pain threshold, endurance and functional capacity, as well as physical performance. In addition, the HBOT group reported significant improvements in induced fatigue and perceived pain at rest. <view study> Read Less

This study was designed to clarify the mechanisms by which 1.3 ATA (ambient air) hyperbaric therapy  improves endurance and interval exercise capacities in highly trained mice. During sprint interval training, the results showed an increase in the proportion of type 1 muscle fibers and promoted the growth of blood vessels and muscle fibers. These results may lead to a new strategy for enhancing exercise capacity in well-trained mice.” <view study> Read Less

'Exercise training and HBO2 exposure stimulate mitochondrial biogenesis, increase capillary density, and induce adaptive antioxidant mechanisms' 49 Healthy long-term intermediate-altitude residents were randomized into 2 groups: one performing six sessions of a SIT regimen over two weeks in a hyperbaric chamber (1.4 ATA); the other performing under ambient pressure conditions (0.85 ATA) The results of this study demonstrated an improvement of cardiorespiratory fitness in the hyperbaric group, reflected by a a significantly higher increase in peak work rate and VE. <view study> Read Less

Now published in the 2018 Journal of Diabetes, research confirms some of the recently noted benefits of mild hyperbaric oxygen (m-HBOT) therapy for diabetics. Specifically, in lowering fasting and non-fasting glucose, HbA1c, and triglyceride levels; all of which are important markers leading to advanced disease states associated with this diabetes. Researchers also focused on skeletal muscle activity and fibers, and found that m-HBOT was able to help the muscle’s natural ability to use oxygen (which is typically compromised in diabetics). By helping to sensitize sugar metabolism and oxygen use within the skeletal muscles, m-HBOT can provide a significant benefit for people with diabetes. It should be noted however, that this protocol provided rats with m-HBOT daily (3 hours per day) for 22 consecutive weeks (about 5 months). <view study> Read Less

Mild or lower pressure hyperbaric oxygen therapy (aka m-HBOT) was able to demonstrate a marked reduction in Parkinson’s Disease (PD) symptoms in just 11 weeks! PD is a common progressive neurodegenerative disease, of which the main neuropathological hallmark is dopaminergic neuronal loss (degeneration or loss of dopamine-producing neuronal cells). When dopamine-producing neurons die, motor functioning is affected and symptoms such as tremor, slowness, stiffness, and balance problems occur. In this 11 week study, m-HBOT at 1.3 ATA (3 hours per day, 3 times per week) was able to protect the dopaminergic neurons from further loss and degeneration. More importantly, researchers observed positive effects in motor function <view study> Read Less